Fundraising Fox

Petra Pharma

New York, US · Founded 2015 · Delaware corporation · 6 known investors

Biotech

Founders & leadership

BO
Brian O'CallaghanExecutive
DR
David RenasExecutive
AY
Albert YuNamed on SEC filing
DM
David McElligottNamed on SEC filing

Board

SG
Steve GillisBoard director
JM
Joel MarcusBoard director
BD
Barbara DaltonBoard director
MJ
M. Johnston ErwinBoard director
TL
Thong LeBoard director
PS
Paul SekhriBoard director

Investors · 6

180 Degree CapitalreportedMenlo Park
AbbViereportedCambridge · $300K – $3M
AlexandriareportedPasadena
ARCH Venture PartnersreportedChicago · $50K – $250M
Johnson & Johnson Innovation – JJDCreportedNew Brunswick
Pfizer Venture Investmentsreported$5M – $20M

Reported raises · per SEC filings

Form D private placements

$58.8M disclosed across 2 rounds · 2015–2018

▶$27.5MraisedMar 2020 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steve GillisDirector
  • M. Johnston ErwinDirector
  • Barbara DaltonDirector
  • Jenna FogerDirector
  • Paul SekhriDirector
  • Thong LeDirector, Promoter
  • David McElligottExecutive Officer, Promoter
  • David RenasExecutive Officer
  • Albert YuExecutive Officer
  • Lindsay RaylePromoter
  • David SchubertPromoter
  • Brian O'CallaghanExecutive Officer, Director
Offering amount
$27.5M
Amount sold
$27.5M
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$31.2MraisedJan 2018 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lindsay RaylePromoter
  • Paul SekhriDirector
  • David SchubertPromoter
  • Steve GillisDirector
  • Joel MarcusDirector
  • Barbara DaltonDirector
  • Brian O'CallaghanExecutive Officer, Director
  • M. Johnston ErwinDirector
  • David RenasExecutive Officer
  • Albert YuExecutive Officer, Promoter
  • David McElligottExecutive Officer, Promoter
  • Thong LeDirector, Promoter
Offering amount
$48.3M
Amount sold
$31.2M
First sale
Dec 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Petra Pharma and Schrödinger Announce Research Collaborationprnewswire.com · Sep 2017Petra Pharma Appoints Executive And Scientific Leadership Teams - BioSpacebiospace.com · Jul 2017What You Need to Know About Petra Pharma - BioSpacebiospace.com · Jan 2017Sprint Bioscience Inks Deal Worth $243 Million for PIP4K2-Program with Petra Pharma - BioSpacebiospace.com · Jul 2016Petra Pharma Raises $48M in Series A Funding | FinSMEsfinsmes.com · Jan 2016

Frequently asked questions

Who are Petra Pharma's investors?
Petra Pharma's investors include 180 Degree Capital, AbbVie, Alexandria, ARCH Venture Partners, Johnson & Johnson Innovation – JJDC, Pfizer Venture Investments.
How much funding has Petra Pharma raised?
Petra Pharma has disclosed $58.8M raised across 2 rounds.
Where is Petra Pharma headquartered?
Petra Pharma is headquartered in New York, US.